Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 2.04% is 15% below its 5-year average of 2.39%, near the low end of its 5-year range (2.04%–2.87%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.48% below its 12-month average of 2.21%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
2.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
2.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
2.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
2.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
2.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
2.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
4.53%
CURRENT VS TTM AVG
-7.48%
CURRENT VS 3Y AVG
-13.38%
CURRENT VS 5Y AVG
-14.64%
CURRENT VS 10Y AVG
-3.73%
CURRENT VS 15Y AVG
-31.72%
CURRENT VS 20Y AVG
-54.94%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-76.08%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$8.50B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
2.21%
3Y Avg
2.35%
5Y Avg
2.39%
Market Cap
$7.47B
Return on Invested Capital (ROIC)
-10.29%
TTM Avg
-59.01%
3Y Avg
-58.33%
5Y Avg
-53.58%
Market Cap
$7.31B
Return on Invested Capital (ROIC)
-27.10%
TTM Avg
-12.21%
3Y Avg
-19.73%
5Y Avg
-18.73%
Market Cap
$9.74B
Return on Invested Capital (ROIC)
6.58%
TTM Avg
6.66%
3Y Avg
7.75%
5Y Avg
8.24%
Market Cap
$9.75B
Return on Invested Capital (ROIC)
11.29%
TTM Avg
10.92%
3Y Avg
8.93%
5Y Avg
9.01%
Market Cap
$10.31B
Return on Invested Capital (ROIC)
7.64%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.37B
Return on Invested Capital (ROIC)
-24.28%
TTM Avg
-15.13%
3Y Avg
-6.38%
5Y Avg
-2.73%
Market Cap
$6.27B
Return on Invested Capital (ROIC)
6.02%
TTM Avg
9.35%
3Y Avg
-2.77%
5Y Avg
-9.72%
Market Cap
$10.91B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
4.65%
3Y Avg
6.09%
5Y Avg
6.66%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.50B | 2.04% | 2.21% | 2.35% | 2.39% |
| Tempus AI, Inc. (TEM)vs › | $7.47B | -10.29% | -59.01% | -58.33% | -53.58% |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | -27.10% | -12.21% | -19.73% | -18.73% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 6.58% | 6.66% | 7.75% | 8.24% |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 11.29% | 10.92% | 8.93% | 9.01% |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | 7.64% | 12.01% | 15.07% | 15.28% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | 6.02% | 9.35% | -2.77% | -9.72% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | 8.36% | 4.65% | 6.09% | 6.66% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 3.18% | 5.25% | 8.14% | 8.29% |
ROIC
2.0%
ROE
2.5%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 2.04% |
| 2024-12-31 | 2.37% |
| 2023-12-31 | 2.14% |
| 2022-12-31 | 2.87% |
| 2021-12-31 | 2.28% |
| 2020-12-31 | 2.64% |
| 2019-12-31 | 2.36% |
| 2018-12-31 | -1.50% |
| 2017-12-31 | 3.09% |
| 2016-12-31 | 1.07% |
| 2015-12-31 | 3.95% |
| 2014-12-31 | 3.50% |
| 2013-12-31 | 4.04% |
| 2012-12-31 | 6.49% |
| 2011-12-31 | 8.45% |
| 2010-12-31 | 9.17% |
| 2009-12-31 | 8.74% |
| 2008-12-31 | 7.73% |
| 2007-12-31 | 6.71% |
| 2006-12-31 | 8.30% |
| 2005-12-31 | 8.63% |
| 2004-12-31 | 6.96% |
| 2003-12-31 | 12.79% |
| 2002-12-31 | 17.64% |
| 2001-12-31 | 15.39% |
| 2000-12-31 | 9.84% |
| 1999-12-31 | 7.10% |
| 1998-12-31 | 7.88% |
| 1997-12-31 | 7.31% |
| 1996-12-31 | 14.81% |
